August 2024 FDA Recall Timolol Maleate by Fdc Limited
D-0642-2024 - Defective Container

This Class II drug recall was voluntarily initiated by Fdc Limited on August 12, 2024 for the product Timolol Maleate. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0642-2024

Reason for Recall
Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Initiated
08-12-2024
Reported
08-28-2024
Quantity
176,784 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey

Batch or Lot Expiration Information

Lot# : a) 083K063, Exp 10/31/2025; b) 083I091, Exp 08/31/2025.